DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Small Molecule Drugs cited in Aventis Pharma Deutschland GMBH v. Lupin Ltd.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2006-07-17||234||Schering’s ‘258 Patent On May 6, 1986, Schering’s Patent No. 4,587,258 (the ‘258 patent or “Gold patent… U.S. Patent Application No. 635,390, which eventually issues into U.S. Patent No. 4,587,258 (the ‘… of contention involves United States Patent No. 4,587,258, which Aventis licensed from Schering and…for being “anticipated by Gold U.S. 4,587,258” (the ‘258 patent). Id. at LUPRAM 000269-270. The Examiner… enough, the ‘722 patent is a subsequent patent to a patent known as the ‘258 patent, which was approved||External link to document|
|2005-12-02||37||Aventis owns U.S. Patent No. 5,061,722, known as the “ ‘722 patent.” The ‘722 patent involves a pharmaceutical… drug claimed in a patent or the use of which is claimed in a patent, . . . if the…product claimed in a patent or the use of which is claimed in a patent before the expiration… the “pioneer” patent. Id. In this case, Lupin Ltd. certified that Plaintiffs’ patent “is invalid or …SCHWARTZ, HERBERT , PATENT LAW AND PRACTICE , §3.V.A. (4th. Ed. 2003)[hereinafter “Patent Law and Practice||External link to document|
|2006-01-18||46||Aventis owns U.S. Patent No. 5,061,722, known as the “‘722 patent.” The ‘722 patent involves a pharmaceutical…status of the “pioneer” patent, Lupin Ltd. certified that Plaintiffs’ patent “is invalid or will not …‘722 patent, constitutes infringement of one or more of the claims of that patent under…‘722 patent under 35 U.S.C. § 271(b) by actively inducing Lupin Ltd. to infringe the ‘722 patent.” Id…developing a generic version of a patented drug before the patent has expired, and 2) provide the innovative||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|